- The Regueiro Report: DDW 2020
- The Scope: Whither the Device Rep, and Other Post-COVID Concerns for GI Practices
- Tecentriq Plus Avastin Approved as First-Line Treatment for Advanced HCC
- Experimental NASH Treatment Produces Suggestions of Benefit in Trial
- Safety Measures, Reassuring Patients Key for Infusion Centers During COVID-19 Pandemic
- Steady as She Goes: Reopening of America
- The Scope: Talking Reopening With Dr. Brett Bernstein
- Blimey! Scurvy Still Afflicts Some IBD Patients
- Residents’ ‘Crazy Idea’ Helps Ship PPE Masks
- IDSA PPE Recommendations: A Practical Approach to Protect HCWs
- Heavy Metals Linked to Liver Ailments
- IBD in the Time of COVID-19
- Patients With IBS Have High Risk for NAFLD
- Qinlock Approved for Fourth-Line Treatment of GIST
- Living Donor Champs Make an Impact
